Divestiture • Life Science

Transformative Biotech Acquires Summit Biolabs - Direct-to-PCR Technologies

On May 18, 2023, Transformative Biotech acquired life science company Summit Biolabs - Direct-to-PCR Technologies from Summit Biolabs

Acquisition Context
  • This is Transformative Biotech’s 1st transaction in the Life Science sector.
  • This is Transformative Biotech’s 1st transaction in the United States.
  • This is Transformative Biotech’s 1st transaction in Colorado.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary

Date May 18, 2023
Target Summit Biolabs - Direct-to-PCR Technologies
Sector Life Science
Buyer(s) Transformative Biotech
Sellers(s) Summit Biolabs
Deal Type Divestiture

Target Company

Summit Biolabs - Direct-to-PCR Technologies

Evergreen, Colorado, United States
Summit Biolabs' Direct-to-PCR Technologies provides patent-pending technologies for extraction-free/direct-to-PCR testing.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Transformative Biotech

Boulder, Colorado, United States

Category Company
Founded 2023
Sector Life Science
DESCRIPTION

Transformative Biotech is a biotechnology company focused on deploying rapid, highly accurate, direct-to-PCR technologies with the power to transform molecular testing for infectious diseases and cancer. Transformative Biotech was founded in 2023 and is based in Boulder, Colorado.


Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Divestiture 1 of 1
State: Colorado 1 of 1
Country: United States 1 of 1
Year: 2023 1 of 1

Seller Profile 1

SELLER

Summit Biolabs

Evergreen, Colorado, United States

Category Company
Founded 2020
Sector Life Science
DESCRIPTION

Summit Biolabs is a commercial-stage molecular diagnostics company harnessing the power of liquid biopsy to rapidly detect infections like COVID-19, Influenza A/B, bacterial, and sexually transmitted. Summit Biolabs was founded in 2020 and is based in Evergreen, Colorado.


Deal Context for Seller #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Divestiture 1 of 1
State: Colorado 1 of 1
Country: United States 1 of 1
Year: 2023 1 of 1